monitor the movement of #BANKNIFTY, it becomes apparent that the performance of #ICICIBANK and #HDFCBANK holds a pivotal role in shaping its trajectory. Should these two entities demonstrate a breakout, it will likely catalyze a robust upmove in the Banknifty space. Traders are advised to exercise caution, as #BANKNIFTY, upon trading above 52400, signals a need to avoid short positions. Stay informed on the latest #FinancialNews and updates from the #StockMarket to make strategic decisions. share monitor the movement of #BANKNIFTY, it becomes apparent that the performance of #ICICIBANK and #HDFCBANK holds a pivotal role in shaping its trajectory. Should these two entities demonstrate a breakout, it will likely catalyze a robust upmove in the Banknifty space. Traders are advised to exercise caution, as #BANKNIFTY, upon trading above 52400, signals a need to avoid short positions. Stay informed on the latest #FinancialNews and updates from the #StockMarket to make strategic decisions. share
Related Posts
Global Indices GIFT Nifty: 23499 +33 Hangseng: 18483 +81 Dow: 23499 -115 S&P 500: 5283 +6 Nasdaq: 16828 +94 USD / INR: 83.10 Brent Crude: 77.90 GOLD: 2369.40 FII Net (03-06-2024): +6851 DII Net (03-06-2024): +1914 Global Indices GIFT Nifty: 23499 +33 Hangseng: 18483 +81 Dow: 23499 -115 S&P 500: 5283 +6 Nasdaq: 16828 +94 USD / INR: 83.10 Brent Crude: 77.90 GOLD: 2369.40 FII Net (03-06-2024): +6851 DII Net (03-06-2024): +1914
- Raj Gaurav Rai
- June 4, 2024
Global Indices GIFT Nifty: 23499 +33Hangseng: 18483 +81Dow: 23499 -115S&P 500: 5283 +6Nasdaq: 16828 +94USD / INR: 83.10Brent Crude: 77.90GOLD: 2369.40FII Net (03-06-2024): +6851DII Net […]
Dr. Reddys-USA Subsidiary, entered a license agreement with Ingenus Pharmaceuticals, LLC for exclusive rights to commercialize Cyclophosphamide Injection RTD in the U.S.-Sales of the product for the past 12 months ended March 2024 were $51.8 million Dr. Reddys-USA Subsidiary, entered a license agreement with Ingenus Pharmaceuticals, LLC for exclusive rights to commercialize Cyclophosphamide Injection RTD in the U.S.-Sales of the product for the past 12 months ended March 2024 were $51.8 million
- Raj Gaurav Rai
- June 12, 2024
Dr. Reddys -USA Subsidiary, entered a license agreement with Ingenus Pharmaceuticals, LLC for exclusive rights to commercialize Cyclophosphamide Injection RTD in the U.S. -Sales of […]
Global Indices GIFT Nifty: 22393 +5 Hangseng: 18390 +76 Dow: 39056 +172 S&P 500: 5188 -0.03 Nasdaq: 16302 -30 USD / INR: 83.47 Brent Crude: 83.80 GOLD: 2316 FII Net (08-05-2024): -6669 DII Net (08-05-2024): +5929 Global Indices GIFT Nifty: 22393 +5 Hangseng: 18390 +76 Dow: 39056 +172 S&P 500: 5188 -0.03 Nasdaq: 16302 -30 USD / INR: 83.47 Brent Crude: 83.80 GOLD: 2316 FII Net (08-05-2024): -6669 DII Net (08-05-2024): +5929
- Raj Gaurav Rai
- May 9, 2024
Global Indices GIFT Nifty: 22393 +5Hangseng: 18390 +76Dow: 39056 +172S&P 500: 5188 -0.03Nasdaq: 16302 -30USD / INR: 83.47Brent Crude: 83.80GOLD: 2316FII Net (08-05-2024): -6669DII Net […]